21 May 2013
10 February 1992
Thomas Wiggans has been named as chief operating officer of Cytotherapeutics.
10 February 1992
John Byington becomes president of Synthecell and also of its wholly-owned subsidiary company, Genetic Medisyn.
10 February 1992
Greg Phelps is named as president of Neozyme Corporation. He replaces Elliott Hillback, who will remain a director.
10 February 1992
Shareholders of the US pharmaceutical concern Upjohn (see also page 4) have filed a lawsuit which accuses the company's senior...
10 February 1992
Japanese concern Tanabe Seiyaku has set up a subsidiary in Paris, France, to develop medical products. The subsidiary, which is...
10 February 1992
The performance of stocks in the UK's Health and Household sector, after a strong start to the New Year, came...
10 February 1992
Imperial Chemical Industries' German pharmaceutical company, ICI Pharma, is preparing a legal offensive against the German health funds over drug...
10 February 1992
Federfarma, the Italian federation of pharmacists, disagrees with state estimates that the regional governments will pick up a bill of...
10 February 1992
Bulgaria has said it may assist the republics of the Commonwealth of Independent States to develop their pharmaceutical industries,...
10 February 1992
With US Food and Drug Administration advisory panel recommendation of Merck & Co's Proscar (finasteride) last week, as an orally-active...